Determining E&L risk from single-use components can be used to build the level of extractable profiling and PERLs.
Tathagata Ray
Advertisement
Tathagata Ray is Area Manager, Process Development at Millipore India Pvt. Ltd (India).
Articles by Tathagata Ray
The evolution of therapeutic modalities drives the adoption of single-use technologies.
The importance of liposomes as an effective drug delivery system is well accepted in the pharmaceutical industry, but their handling remains a challenge.
Advertisement
Latest Updated Articles
Review of SUT Adoption in Biopharma ManufacturingPublished: March 16th 2024 | Updated:
Improving liposome integrity and easing bottlenecks to productionPublished: June 1st 2009 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
PharmTech Weekly News Roundup – Week of November 3, 2025
2
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
3
AAPS PharmSci 360: Enhancing Bioanalysis with AI and Other Technologies
4
Why Investment Strategies Matter for Advancing Pharmaceutical Technologies
5
